Kayne Anderson MLP Investment Company (KYN) Reaches $18.73 Formed H&S; Exact Sciences (EXAS)’s Sentiment Is 1.15

June 18, 2018 - By rebbecca

Exact Sciences Corporation (NASDAQ:EXAS) Logo

Exact Sciences Corp (EXAS) investors sentiment increased to 1.15 in Q1 2018. It’s up 0.27, from 0.88 in 2017Q4. The ratio increased, as 142 active investment managers opened new and increased positions, while 123 cut down and sold their equity positions in Exact Sciences Corp. The active investment managers in our database now have: 101.92 million shares, up from 92.48 million shares in 2017Q4. Also, the number of active investment managers holding Exact Sciences Corp in top ten positions decreased from 5 to 4 for a decrease of 1. Sold All: 43 Reduced: 80 Increased: 88 New Position: 54.

Kayne Anderson MLP Investment Company (KYN) formed H&S with $17.61 target or 6.00% below today’s $18.73 share price. Kayne Anderson MLP Investment Company (KYN) has $2.16 billion valuation. The stock increased 0.64% or $0.12 during the last trading session, reaching $18.73. About 18,988 shares traded. Kayne Anderson MLP Investment Company (NYSE:KYN) has declined 3.36% since June 18, 2017 and is downtrending. It has underperformed by 15.93% the S&P500.

Investors sentiment increased to 1.06 in 2018 Q1. Its up 0.11, from 0.95 in 2017Q4. It increased, as 12 investors sold Kayne Anderson MLP Investment Company shares while 39 reduced holdings. 10 funds opened positions while 44 raised stakes. 25.42 million shares or 0.56% less from 25.56 million shares in 2017Q4 were reported. Creative Planning has 12,478 shares. Sterneck Ltd reported 0.15% stake. Rivernorth Capital Limited Liability Corporation holds 1.29% or 1.06 million shares in its portfolio. Signature Management owns 149,203 shares for 0.51% of their portfolio. Hightower Advisors Limited Liability Company has 0.01% invested in Kayne Anderson MLP Investment Company (NYSE:KYN) for 45,096 shares. Lakeview Ptnrs Limited Co invested in 0.3% or 23,931 shares. Asset Mngmt Incorporated stated it has 52,550 shares or 0.12% of all its holdings. Mariner Ltd Liability owns 25,000 shares. Bb&T Secs Lc has 0.02% invested in Kayne Anderson MLP Investment Company (NYSE:KYN). Services Corporation accumulated 1,392 shares. Coe Capital Lc has 0.39% invested in Kayne Anderson MLP Investment Company (NYSE:KYN). Sei Company owns 1,833 shares. Private Advisor Grp accumulated 14,197 shares. First Allied Advisory invested in 0.02% or 26,171 shares. Riggs Asset Managment, Pennsylvania-based fund reported 318 shares.

Since May 1, 2018, it had 2 insider purchases, and 0 sales for $500,026 activity. $250,013 worth of stock was bought by KAYNE RICHARD A on Tuesday, May 1. McCarthy Kevin S bought $250,013 worth of stock.

Analysts await Exact Sciences Corporation (NASDAQ:EXAS) to report earnings on July, 24. They expect $-0.33 earnings per share, down 22.22% or $0.06 from last year’s $-0.27 per share. After $-0.33 actual earnings per share reported by Exact Sciences Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Ratings analysis reveals 33% of EXACT Sciences’s analysts are positive. Out of 3 Wall Street analysts rating EXACT Sciences, 1 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $15.0 while the high is $17.0. The stock’s average target of $16 is -77.32% below today’s ($70.54) share price. EXAS was included in 3 notes of analysts from October 26, 2016. The company was maintained on Tuesday, November 1 by Lake Street. As per Wednesday, February 22, the company rating was upgraded by Roth Capital. The firm has “Hold” rating by Benchmark given on Wednesday, October 26.

The stock increased 2.93% or $2.01 during the last trading session, reaching $70.54. About 488,260 shares traded. Exact Sciences Corporation (EXAS) has risen 56.13% since June 18, 2017 and is uptrending. It has outperformed by 43.56% the S&P500. Some Historical EXAS News: ; 21/05/2018 – Exact Sciences Presenting at UBS Conference Tomorrow; 17/04/2018 – Exact Sciences Closes Above 200-Day Moving Average: Technicals; 30/05/2018 – American Cancer Society recommends earlier colorectal cancer screening; 26/04/2018 – EXACT SCIENCES CORP EXAS.O SEES FY 2018 REVENUE $420 MLN TO $430 MLN; 16/03/2018 – Exact Sciences Corp: We admit to being early. But the science won’t be held back; 26/04/2018 – Exact Sciences Closes Above 50-Day Moving Average: Technicals; 01/05/2018 – Exact Sciences to participate in two investor conferences during May; 03/04/2018 – ColoGuard to Provide Industry City Tenants with Ready Access to More Than 30 Networks; 23/04/2018 – DJ Exact Sciences Corporation, Inst Holders, 1Q 2018 (EXAS); 20/03/2018 – Mark Stenhouse to join Exact Sciences as President, Cologuard

Since January 1, 0001, it had 0 buys, and 21 selling transactions for $25.11 million activity.

Antipodean Advisors Llc holds 10.54% of its portfolio in Exact Sciences Corporation for 236,346 shares. Zevenbergen Capital Investments Llc owns 2.03 million shares or 3.15% of their US portfolio. Moreover, Sectoral Asset Management Inc has 2.54% invested in the company for 574,049 shares. The Alabama-based Zweig has invested 2.29% in the stock. Elk Creek Partners Llc, a Colorado-based fund reported 962,731 shares.

Exact Sciences Corporation (NASDAQ:EXAS) Institutional Positions Chart